Article

BAP1 Loss Predicts Therapeutic Vulnerability in Malignant Peritoneal Mesothelioma

2018-03-15

Abstract excerpt

<h4>Background</h4> Malignant Peritoneal Mesothelioma (PeM) is a rare but frequently fatal cancer that originates from the peritoneal lining of the abdomen. Standard treatment of PeM is limited to cytoreductive surgery and/or chemotherapy, and no effective targeted therapies for PeM yet exist. In the search for novel therapeutic target candidates in PeM, we performed a comprehensive integrative multi-omics analys...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 14ac6517-e5a8-511c-b138-2adcf7ce9ed3
DOI: 10.1101/243477

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

BAP1 Loss Predicts Therapeutic Vulnerability in Malignant Peritoneal MesotheliomaDOI 10.1101/243477Read

BAP1 haploinsufficiency predicts a distinct immunogenic class of malignant peritoneal mesotheliomaSemantic proximity Read

Inactivation of BAP1 and the Hippo Pathway Defines the Mutational Landscape of Peritoneal MesotheliomaSemantic proximity Read

Integrative Molecular Characterization of Malignant Pleural Mesothelioma.Semantic proximity Read

Isolated BAP1 Genomic Alteration in Malignant Pleural Mesothelioma Predicts Distinct Immunogenicity with Implications for Immunotherapeutic ResponseSemantic proximity Read

Comprehensive genomic and transcriptomic analysis enables molecularly guided therapy options in peritoneal and pleural mesotheliomaSemantic proximity Read

Molecular alterations and potential actionable mutations in peritoneal mesothelioma: a scoping review of high-throughput sequencing studies.Semantic proximity Read

Isolated <i>BAP1</i> loss in malignant pleural mesothelioma predicts immunogenicity with implications for immunotherapeutic responseSemantic proximity Read

Establishment and Histopathological Study of Patient-derived Xenograft Models and Primary Cell Lines of Epithelioid Malignant Peritoneal MesotheliomaSemantic proximity Read

Alterations in BAP1 Are Associated with Cisplatin Resistance through Inhibition of Apoptosis in Malignant Pleural MesotheliomaSemantic proximity Read

Genomic characterization and detection of potential therapeutic targets for peritoneal mesothelioma in current practice.Semantic proximity Read

Large-scale analysis of BAP1 expression reveals novel associations with clinical and molecular features of malignant pleural mesothelioma.Semantic proximity Read

BAP1: Not just a BRCA1-associated proteinSemantic proximity Read